ESMO25 Breast Cancer Highlights: monarchE and NATALEE | Dana-Farber Cancer Institute

21 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the monarchE and NATALEE trials, investigating CDK4/6 inhibitors for high-risk, early stage, HR+ breast cancer, which were presented at ESMO 2025.

For more information about Dana-Farber's Breast Oncology Center, visit https://www.dana-farber.org/cancer-care/treatment/breast-oncology
Categoria
Oncology
Commenta per primo questo video.

Prossimo